UPLUNIR, created in 2014 (United Kingdom), from 248 sister brands and 17477 competing brands. The UPLUNIR brand is owned by GLAXOSMITHKLINE, a company listed in London. The International Securities Identification Number (ISIN) of GLAXOSMITHKLINE is GB0009252882. UPLUNIR belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
GLAXOSMITHKLINE
(UPLUNIR)
over 5 years*
GBX 1,404.79